Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Insulet (PODD) Q1 Earnings and Revenues Surpass Estimates
Insulet (PODD) Q1 Earnings and Revenues Surpass Estimates

Insulet (PODD) came out with quarterly earnings of $1.02 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.73 per share a year ago. These figures

Pacira (PCRX) Q1 Earnings Surpass Estimates
Pacira (PCRX) Q1 Earnings Surpass Estimates

Pacira (PCRX) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.62 per share a year ago. These figures are

Nerdy Inc. (NRDY) Reports Q1 Loss, Tops Revenue Estimates
Nerdy Inc. (NRDY) Reports Q1 Loss, Tops Revenue Estimates

Nerdy Inc. (NRDY) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.07 per share a year ago. These figures are

1-800-Flowers.com (FLWS) Reports Q3 Loss, Lags Revenue Estimates
1-800-Flowers.com (FLWS) Reports Q3 Loss, Lags Revenue Estimates

1-800-Flowers.com (FLWS) came out with a quarterly loss of $0.71 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.28 per share a year ago. These figures

Expedia (EXPE) Misses Q1 Earnings and Revenue Estimates
Expedia (EXPE) Misses Q1 Earnings and Revenue Estimates

Expedia (EXPE) came out with quarterly earnings of $0.40 per share, missing the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.21 per share a year ago. These figures

Lyft (LYFT) Misses Q1 Earnings and Revenue Estimates
Lyft (LYFT) Misses Q1 Earnings and Revenue Estimates

Lyft (LYFT) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.15 per share a year ago. These figures are

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass EstimatesPhoto, wide shot, wide-angle lens,  Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates

Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.45 per share a year ago

Federal Realty Investment Trust (FRT) Q1 FFO and Revenues Top Estimates
Federal Realty Investment Trust (FRT) Q1 FFO and Revenues Top Estimates

Federal Realty Investment Trust (FRT) came out with quarterly funds from operations (FFO) of $1.70 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to FFO of $1.64

Clearfield (CLFD) Q2 Earnings and Revenues Top Estimates
Clearfield (CLFD) Q2 Earnings and Revenues Top Estimates

Clearfield (CLFD) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of a loss of $0.19 per share. This compares to loss of $0.40 per share a year ago. These

Akamai Technologies (AKAM) Q1 Earnings and Revenues Top Estimates
Akamai Technologies (AKAM) Q1 Earnings and Revenues Top Estimates

Akamai Technologies (AKAM) came out with quarterly earnings of $1.70 per share, beating the Zacks Consensus Estimate of $1.58 per share. This compares to earnings of $1.64 per share a year ago

Celldex Therapeutics (CLDX) Reports Q1 Loss, Lags Revenue Estimates
Celldex Therapeutics (CLDX) Reports Q1 Loss, Lags Revenue Estimates

Celldex Therapeutics (CLDX) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to loss of $0.56 per share a year ago. These

Paramount Global (PARAA) Misses Q1 Earnings and Revenue Estimates
Paramount Global (PARAA) Misses Q1 Earnings and Revenue Estimates

Paramount Global (PARAA) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.62 per share a year ago. These

Jushi Holdings Inc. (JUSHF) Reports Q1 Loss, Lags Revenue Estimates
Jushi Holdings Inc. (JUSHF) Reports Q1 Loss, Lags Revenue Estimates

Jushi Holdings Inc. (JUSHF) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to loss of $0.09 per share a year ago. These

Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates
Harrow (HROW) Reports Q1 Loss, Lags Revenue Estimates

Harrow (HROW) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of $0.02. This compares to loss of $0.28 per share a year ago. These figures are adjusted for

Curaleaf Holdings, Inc. (CURLF) Reports Q1 Loss, Lags Revenue Estimates
Curaleaf Holdings, Inc. (CURLF) Reports Q1 Loss, Lags Revenue Estimates

Curaleaf Holdings, Inc. (CURLF) came out with a quarterly loss of $0.07 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.07 per share a year ago. These figures are

Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates
Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates

Arcellx, Inc. (ACLX) came out with a quarterly loss of $1.13 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to loss of $0.14 per share a year ago. These figures are

U.S. Physical Therapy (USPH) Beats Q1 Earnings Estimates (Revised)
U.S. Physical Therapy (USPH) Beats Q1 Earnings Estimates (Revised)

U.S. Physical Therapy (USPH) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.51 per share a year ago

Making Sense of Earnings Estimates Revisions Trend
Making Sense of Earnings Estimates Revisions Trend

The ongoing tariff uncertainty has been weighing on the earnings outlook in recent weeks, prompting analysts to cut their estimates for the coming periods. This trend has been showing in estimates

Top Stock Reports for NVIDIA, Abbott Laboratories & LindePhoto, wide shot, wide-angle lens,  Consumer electronics manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.theapi.app/temp/d8a4268f-c982-4aa8-a09e-f9ee1db62f57.png
Top Stock Reports for NVIDIA, Abbott Laboratories & Linde

Thursday, May 8, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp.

Ferroglobe (GSM) Reports Q1 Loss, Misses Revenue Estimates (Revised)
Ferroglobe (GSM) Reports Q1 Loss, Misses Revenue Estimates (Revised)

Ferroglobe (GSM) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.12. This compares to break-even earnings per share a year ago. These figures

Buy the Spike in AMD Stock After Q1 Earnings?Photo, wide shot, wide-angle lens,  Artificial intelligence developer, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/ee32e77c-b7d6-424b-91ea-4023f2292688.png
Buy the Spike in AMD Stock After Q1 Earnings?

Advanced Micro Devices’ AMD stock has risen 5% since surpassing its Q1 expectations on Tuesday, with the post-earnings rally gaining steam as President Trump boosted markets by announcing a new

Can NOW's Strong Portfolio & Rich Partner Base Push the Stock Higher?
Can NOW's Strong Portfolio & Rich Partner Base Push the Stock Higher?

ServiceNow NOW shares have lost 7.2% year to date compared with the Zacks Computer & Technology sector and the Zacks Computers – IT Services industry’s decline of 8.7% and 10.2%, respectively. The

Is Medtronic Stock a Buy Pre-Q4 Earnings? Key Metrics to Watch
Is Medtronic Stock a Buy Pre-Q4 Earnings? Key Metrics to Watch

Medtronic plc MDT is scheduled to report fourth-quarter and full-year fiscal 2025 results on May 21, before the opening bell.

In the last reported quarter, the company’s adjusted earnings of $1.39

Amazon Issues Mixed Q2 Guidance: Buy, Sell or Hold the Stock?
Amazon Issues Mixed Q2 Guidance: Buy, Sell or Hold the Stock?

Amazon AMZN delivered strong first-quarter 2025 results with earnings of $1.59 per share, which beat estimates by 17.78% and increased 40.7% year over year. Net sales reached $155.7 billion, up 9%

NPK Stock Down 8% Despite Q1 Earnings Rise Y/Y on Higher Defense SalesPhoto, wide shot, wide-angle lens,  Heavy machinery, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/c15253b0-7330-4605-a666-66954eaf6715.png
NPK Stock Down 8% Despite Q1 Earnings Rise Y/Y on Higher Defense Sales

Shares of National Presto Industries, Inc. NPK have declined 8.2% since the company reported its earnings for the quarter ended March 30, 2025. This compares to the S&P 500 index’s 0.3% decline over